We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+23.15%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$27.2B
AUM Growth
+$4.48B
(+20%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
7.53%
Top 10 Holdings %
Top 10 Hldgs %
39.03%
Holding
3,928
New
1,420
Increased
825
Reduced
534
Closed
1,145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$599M |
| 2 |
NVIDIA
NVDA
|
+$586M |
| 3 |
Microsoft
MSFT
|
+$285M |
| 4 |
Amphenol
APH
|
+$191M |
| 5 |
Johnson & Johnson
JNJ
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$727M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$441M |
| 3 |
Palantir
PLTR
|
+$307M |
| 4 |
Thomson Reuters
TRI
|
+$279M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.7% |
| 2 | Financials | 7% |
| 3 | Healthcare | 5.22% |
| 4 | Industrials | 4.77% |
| 5 | Consumer Discretionary | 4.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
CALL
DexCom
DXCM
$32B
| $672K | ﹤0.01% |
+10,000
| New | +$791K |
|
1727
Takeda Pharmaceutical
TAK
$55.7B
| $669K | ﹤0.01% |
45,732
+4,959
| +12% | +$73.6K |
|
|
PLTY
1728
YieldMax PLTR Option Income Strategy ETF
PLTY
$407M
| $665K | ﹤0.01% |
+10,190
| New | +$669K |
|
1729
CALL
Walt Disney
DIS
$181B
| $664K | ﹤0.01% |
5,800
-46,300
| -89% | -$5.45M |
|
1730
CALL
Williams-Sonoma
WSM
$29.6B
| $664K | ﹤0.01% |
+3,400
| New | +$650K |
|
1731
S&T Bancorp
STBA
$1.79B
| $663K | ﹤0.01% |
+17,657
| New | +$678K |
|
1732
Gabelli Equity Trust
GAB
$1.79B
| $662K | ﹤0.01% |
+108,835
| New | +$653K |
|
1733
Powell Industries
POWL
$7.71B
| $661K | ﹤0.01% |
+6,510
| New | +$552K |
|
1734
GDS Holdings
GDS
$6.41B
| $659K | ﹤0.01% |
+17,050
| New | +$604K |
|
1735
Lakeland Financial Corp
LKFN
$1.53B
| $659K | ﹤0.01% |
+10,269
| New | +$667K |
|
1736
Vanguard High Dividend Yield ETF
VYM
$82.8B
| $659K | ﹤0.01% |
+4,679
| New | +$643K |
|
1737
Adient
ADNT
$1.5B
| $658K | ﹤0.01% |
27,334
-55,299
| -67% | -$1.29M |
|
1738
Royal Bank of Canada
RY
$293B
| $658K | ﹤0.01% |
+4,471
| New | +$616K |
|
1739
Turkcell
TKC
$4.79B
| $657K | ﹤0.01% |
+109,207
| New | +$638K |
|
1740
GFL Environmental
GFL
$14.9B
| $656K | ﹤0.01% |
+13,851
| New | +$671K |
|
1741
iShares Floating Rate Bond ETF
FLOT
$10.3B
| $655K | ﹤0.01% |
+12,840
| New | +$654K |
|
1742
Simplify Aggregate Bond ETF
AGGH
$579M
| $653K | ﹤0.01% |
+31,541
| New | +$649K |
|
1743
Pharvaris
PHVS
$2.44B
| $653K | ﹤0.01% |
+26,202
| New | +$581K |
|
1744
TechTarget
TTGT
$278M
| $651K | ﹤0.01% |
+112,123
| New | +$743K |
|
1745
CALL
UiPath
PATH
$7.8B
| $644K | ﹤0.01% |
+48,200
| New | +$570K |
|
1746
First Merchants
FRME
$2.67B
| $642K | ﹤0.01% |
17,032
-10,268
| -38% | -$410K |
|
1747
WesBanco
WSBC
$4B
| $641K | ﹤0.01% |
+20,094
| New | +$641K |
|
|
EXAS
1748
PUT
DELISTED
Exact Sciences
EXAS
| $640K | ﹤0.01% |
+11,700
| New | +$585K |
|
1749
Atlas Energy Solutions
AESI
$1.41B
| $639K | ﹤0.01% |
+56,208
| New | +$689K |
|
1750
VanEck Morningstar Wide Moat ETF
MOAT
$12.3B
| $639K | ﹤0.01% |
+6,454
| New | +$630K |
|
Similar funds
DB
HRT Financial's Q3 2025 Portfolio in Review
As of Q3 2025, HRT Financial held 3,928 positions worth $27.2B, up 20% from $22.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
HRT Financial deployed $2.05B of net new capital in Q3 2025, opening 1,420 new positions and adding to 825 existing holdings. Its largest new stake was NVIDIA: 3,361,930 shares worth $627M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 6.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $441M trimmed.
- HRT Financial's largest Q3 2025 buy was NVIDIA: 3,361,930 shares worth $627M.
- HRT Financial added most to Apple in Q3 2025, an estimated $599M increase.
- HRT Financial's biggest Q3 2025 reduction was Invesco QQQ Trust, cutting an estimated $441M.
- HRT Financial fully exited Applovin in Q3 2025, selling an estimated $727M.
- HRT Financial's ten largest holdings make up 39% of its $27.2B portfolio in Q3 2025.
- HRT Financial opened 1,420 new positions and closed 1,145 in Q3 2025.
- HRT Financial's portfolio value rose 20% quarter-over-quarter to $27.2B.
Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.